Here, we utilized a doxycycline-inducible adipocyte Hif1a knockout mice to evaluate the muscle-protective effects of metabolically healthy AT remodeling in the context of co-occurring sarcopenia and obesity. The gene discussed is HIF1A; the disease is obesity disorder.